These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

895 related items for PubMed ID: 25403813

  • 1. Mindfulness-based cognitive therapy in obsessive-compulsive disorder: protocol of a randomized controlled trial.
    Külz AK, Landmann S, Cludius B, Hottenrott B, Rose N, Heidenreich T, Hertenstein E, Voderholzer U, Moritz S.
    BMC Psychiatry; 2014 Nov 18; 14():314. PubMed ID: 25403813
    [Abstract] [Full Text] [Related]

  • 2. Mindfulness-based cognitive therapy (MBCT) in patients with obsessive-compulsive disorder (OCD) and residual symptoms after cognitive behavioral therapy (CBT): a randomized controlled trial.
    Külz AK, Landmann S, Cludius B, Rose N, Heidenreich T, Jelinek L, Alsleben H, Wahl K, Philipsen A, Voderholzer U, Maier JG, Moritz S.
    Eur Arch Psychiatry Clin Neurosci; 2019 Mar 18; 269(2):223-233. PubMed ID: 30446822
    [Abstract] [Full Text] [Related]

  • 3. Mindfulness-based cognitive therapy as an augmentation treatment for obsessive-compulsive disorder.
    Key BL, Rowa K, Bieling P, McCabe R, Pawluk EJ.
    Clin Psychol Psychother; 2017 Sep 18; 24(5):1109-1120. PubMed ID: 28194835
    [Abstract] [Full Text] [Related]

  • 4. Long-term effects of mindfulness-based cognitive therapy in patients with obsessive-compulsive disorder and residual symptoms after cognitive behavioral therapy: Twelve-month follow-up of a randomized controlled trial.
    Cludius B, Landmann S, Rose N, Heidenreich T, Hottenrott B, Schröder J, Jelinek L, Voderholzer U, Külz AK, Moritz S.
    Psychiatry Res; 2020 Sep 18; 291():113119. PubMed ID: 32534361
    [Abstract] [Full Text] [Related]

  • 5. Pallidum volume as a predictor for the effectiveness of mindfulness-based cognitive therapy and psycho-education in unmedicated patients with obsessive-compulsive disorder.
    Zhang C, Zhang X, Li W, Zhang T, Zhang Z, Lu L, Didonna F, Fan Q.
    Compr Psychiatry; 2024 May 18; 131():152462. PubMed ID: 38354586
    [Abstract] [Full Text] [Related]

  • 6. Participant perspectives on the acceptability and effectiveness of mindfulness-based cognitive behaviour therapy approaches for obsessive compulsive disorder.
    Leeuwerik T, Cavanagh K, Forrester E, Hoadley C, Jones AM, Lea L, Rosten C, Strauss C.
    PLoS One; 2020 May 18; 15(10):e0238845. PubMed ID: 33085672
    [Abstract] [Full Text] [Related]

  • 7. Therapist-Assisted Internet-Based Cognitive Behavioral Therapy Versus Progressive Relaxation in Obsessive-Compulsive Disorder: Randomized Controlled Trial.
    Kyrios M, Ahern C, Fassnacht DB, Nedeljkovic M, Moulding R, Meyer D.
    J Med Internet Res; 2018 Aug 08; 20(8):e242. PubMed ID: 30089607
    [Abstract] [Full Text] [Related]

  • 8. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
    Simpson HB, Foa EB, Liebowitz MR, Huppert JD, Cahill S, Maher MJ, McLean CP, Bender J, Marcus SM, Williams MT, Weaver J, Vermes D, Van Meter PE, Rodriguez CI, Powers M, Pinto A, Imms P, Hahn CG, Campeas R.
    JAMA Psychiatry; 2013 Nov 08; 70(11):1190-9. PubMed ID: 24026523
    [Abstract] [Full Text] [Related]

  • 9. ØCD: protocol for the development and evaluation of a cognitive-behavioral prevention program for obsessive-compulsive disorder.
    Cardoș RAI, Dumitru EP, David OA.
    BMC Psychiatry; 2024 May 09; 24(1):348. PubMed ID: 38724961
    [Abstract] [Full Text] [Related]

  • 10. Mindfulness as a therapeutic option for obsessive-compulsive disorder.
    Reis A, Westhoff M, Quintarelli H, Hofmann SG.
    Expert Rev Neurother; 2024 Aug 09; 24(8):735-741. PubMed ID: 38889066
    [Abstract] [Full Text] [Related]

  • 11. Clinical effectiveness, cost-effectiveness and acceptability of low-intensity interventions in the management of obsessive-compulsive disorder: the Obsessive-Compulsive Treatment Efficacy randomised controlled Trial (OCTET).
    Lovell K, Bower P, Gellatly J, Byford S, Bee P, McMillan D, Arundel C, Gilbody S, Gega L, Hardy G, Reynolds S, Barkham M, Mottram P, Lidbetter N, Pedley R, Molle J, Peckham E, Knopp-Hoffer J, Price O, Connell J, Heslin M, Foley C, Plummer F, Roberts C.
    Health Technol Assess; 2017 Jun 09; 21(37):1-132. PubMed ID: 28681717
    [Abstract] [Full Text] [Related]

  • 12. How resistant is 'treatment-resistant' obsessive-compulsive disorder in youth?
    Krebs G, Isomura K, Lang K, Jassi A, Heyman I, Diamond H, Advani J, Turner C, Mataix-Cols D.
    Br J Clin Psychol; 2015 Mar 09; 54(1):63-75. PubMed ID: 25130442
    [Abstract] [Full Text] [Related]

  • 13. Low-intensity cognitive-behaviour therapy interventions for obsessive-compulsive disorder compared to waiting list for therapist-led cognitive-behaviour therapy: 3-arm randomised controlled trial of clinical effectiveness.
    Lovell K, Bower P, Gellatly J, Byford S, Bee P, McMillan D, Arundel C, Gilbody S, Gega L, Hardy G, Reynolds S, Barkham M, Mottram P, Lidbetter N, Pedley R, Molle J, Peckham E, Knopp-Hoffer J, Price O, Connell J, Heslin M, Foley C, Plummer F, Roberts C.
    PLoS Med; 2017 Jun 09; 14(6):e1002337. PubMed ID: 28654682
    [Abstract] [Full Text] [Related]

  • 14. A randomized controlled trial of mindfulness-based cognitive therapy vs stress management training for obsessive-compulsive disorder.
    Mathur S, Sharma MP, Balachander S, Kandavel T, Reddy YJ.
    J Affect Disord; 2021 Mar 01; 282():58-68. PubMed ID: 33401124
    [Abstract] [Full Text] [Related]

  • 15. Remission and Relapse Across Three Years in Pediatric Obsessive-Compulsive Disorder Following Evidence-Based Treatments.
    Ivarsson T, Jensen S, Højgaard DRMA, Hybel KA, Torp NC, Melin K, Nissen JB, Weidle B, Thomsen PH, Dahl K, Skarphedinsson G.
    J Am Acad Child Adolesc Psychiatry; 2024 May 01; 63(5):519-527. PubMed ID: 38070870
    [Abstract] [Full Text] [Related]

  • 16. Study protocol for a single-blind, randomised controlled, non-inferiority trial of internet-based versus face-to-face cognitive behaviour therapy for obsessive-compulsive disorder.
    Rück C, Lundström L, Flygare O, Enander J, Bottai M, Mataix-Cols D, Andersson E.
    BMJ Open; 2018 Sep 05; 8(9):e022254. PubMed ID: 30185575
    [Abstract] [Full Text] [Related]

  • 17. Family-based cognitive behavioural therapy versus family-based relaxation therapy for obsessive-compulsive disorder in children and adolescents: protocol for a randomised clinical trial (the TECTO trial).
    Pagsberg AK, Uhre C, Uhre V, Pretzmann L, Christensen SH, Thoustrup C, Clemmesen I, Gudmandsen AA, Korsbjerg NLJ, Mora-Jensen AC, Ritter M, Thorsen ED, Halberg KSV, Bugge B, Staal N, Ingstrup HK, Moltke BB, Kloster AM, Zoega PJ, Mikkelsen MS, Harboe GS, Larsen KF, Clemmensen LKH, Lindschou J, Jakobsen JC, Engstrøm J, Gluud C, Siebner HR, Thomsen PH, Hybel K, Verhulst F, Jeppesen P, Jepsen JRM, Vangkilde S, Olsen MH, Hagstrøm J, Lønfeldt NN, Plessen KJ.
    BMC Psychiatry; 2022 Mar 19; 22(1):204. PubMed ID: 35305587
    [Abstract] [Full Text] [Related]

  • 18. Clinical predictors of long-term outcome in obsessive-compulsive disorder.
    Jakubovski E, Diniz JB, Valerio C, Fossaluza V, Belotto-Silva C, Gorenstein C, Miguel E, Shavitt RG.
    Depress Anxiety; 2013 Aug 19; 30(8):763-72. PubMed ID: 23109056
    [Abstract] [Full Text] [Related]

  • 19. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis.
    Issari Y, Jakubovski E, Bartley CA, Pittenger C, Bloch MH.
    J Clin Psychiatry; 2016 May 19; 77(5):e605-11. PubMed ID: 27249090
    [Abstract] [Full Text] [Related]

  • 20. Personalized exposure and experience sampling method feedback versus exposure as usual for obsessive-compulsive disorder: a study protocol for a randomized controlled trial.
    Hoogerwerf E, Greeven A, Goekoop R, Spinhoven P.
    Trials; 2024 Jan 12; 25(1):43. PubMed ID: 38217045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.